MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

300 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q2 2018.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 249 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 73,460,919 shares of 93,104,451 outstanding shares and own 79% of the company stock.
Largest 10 shareholders include BlackRock Inc. (11,083,521 shares), BAILLIE GIFFORD & CO (9,455,185 shares), VANGUARD GROUP INC (8,291,236 shares), D. E. Shaw & Co., Inc. (4,050,733 shares), STATE STREET CORP (3,128,672 shares), DIMENSIONAL FUND ADVISORS LP (3,055,263 shares), Thrivent Financial for Lutherans (2,856,846 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (2,376,935 shares), ACADIAN ASSET MANAGEMENT LLC (2,327,720 shares), and NORTHERN TRUST CORP (1,801,882 shares).
This table shows the top 249 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.